Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
33,065
Value
$1.80M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,065$1.80M<0.1%−4,543−12.1%ReducedHolders
Q1 202637,608$1.79M<0.1%+10,719+39.9%AddedHolders
Q4 202526,889$1.41M<0.1%−2,714−9.2%ReducedHolders
Q3 202529,603$1.92M<0.1%+13,762+86.9%AddedHolders
Q2 202515,841$770.5K<0.1%+2,263+16.7%AddedHolders
Q1 202513,578$462.1K<0.1%+461+3.5%AddedHolders
Q4 202413,117$516.3K<0.1%−554−4.1%ReducedHolders
Q3 202413,671$642.3K<0.1%−1,079−7.3%ReducedHolders
Q2 202414,750$796.6K<0.1%+456+3.2%AddedHolders
Q1 202414,294$974.3K<0.1%+484+3.5%AddedHolders
Q4 202313,810$864.5K<0.1%−1,140−7.6%ReducedHolders
Q3 202314,950$678.6K<0.1%+5,702+61.7%AddedHolders
Q2 20239,248$519.2K<0.1%−147−1.6%ReducedHolders
Q1 20239,395$424.9K<0.1%−2,400−20.3%ReducedHolders
Q4 202211,795$479.5K<0.1%−182−1.5%ReducedHolders
Q3 202211,977$783.0K<0.1%+792+7.1%AddedHolders
Q2 202211,185$680.0K<0.1%+904+8.8%AddedHolders
Q1 202210,281$645.0K<0.1%+491+5.0%AddedHolders
Q4 20219,790$742.0K<0.1%−2,380−19.6%ReducedHolders
Q3 202112,170$1.36M<0.1%+2,742+29.1%AddedHolders
Q2 20219,428$1.53M<0.1%−3,924−29.4%ReducedHolders
Q1 202113,352$1.63M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.